Meet BS PHARM KOREA at IMCAS China 2026 as an Official Silver Sponsor, featuring INHILO and NA:DRN.
Introduction
IMCAS China 2026 is one of Asia’s leading scientific congresses for dermatology, plastic surgery, and medical aesthetics. Each year, the congress brings together physicians, researchers, distributors, and industry innovators to exchange scientific knowledge, discover emerging technologies, and explore the future of regenerative aesthetic medicine.
As China’s medical aesthetics market enters a new phase of high-quality growth, the industry is placing greater emphasis on clinical safety, scientific evidence, standardized practice, and professional education. According to the official IMCAS welcome message, these principles are shaping the next generation of aesthetic medicine and driving innovation across the global industry.
This year, BS PHARM KOREA is proud to participate as an official Silver Sponsor, introducing INHILO and NA:DRN while meeting global physicians and distribution partners who share the same commitment to evidence-based regenerative aesthetics.
Why IMCAS China 2026 Matters
Unlike a conventional trade exhibition, IMCAS China combines scientific education with clinical innovation.
The congress serves as an international platform where experts discuss practical treatment strategies, evaluate emerging technologies, and share real-world clinical experience. Through lectures, panel discussions, live demonstrations, and industry collaboration, IMCAS helps translate scientific research into everyday clinical practice.
For companies developing regenerative aesthetic solutions, IMCAS China provides an ideal environment to exchange knowledge with healthcare professionals and understand the evolving needs of the global market.
IMCAS China 2025 Highlights
The previous edition demonstrated why IMCAS China has become one of Asia’s most influential scientific congresses for medical aesthetics.
According to the official IMCAS China report, the 2025 congress featured:
- – 2,009 participants
- – 67 participating countries & regions
- – 224 international faculty members
- – 74 scientific sessions
- – 589 scientific presentations
- – 115+ learning hours
- – 59 sponsoring companies
These figures highlight IMCAS China’s continued growth as one of Asia’s most influential scientific congresses for medical aesthetics and reinforce its value as a platform for global clinical collaboration.
Scientific Focus of IMCAS China 2026
One of the strengths of IMCAS China is its comprehensive scientific program covering every major field of modern aesthetic medicine.
According to the official program, Injectables represent the largest educational category, with approximately 26 hours of scientific sessions, followed by Face Surgery and topics covering regenerative medicine, combination therapies, and emerging technologies. This strong emphasis reflects the industry’s continued shift toward minimally invasive procedures and advanced injectable technologies designed to improve long-term skin quality.
These scientific priorities closely align with BS PHARM KOREA’s regenerative aesthetics portfolio.
Why BS PHARM KOREA Is Participating
For BS PHARM KOREA, participating in IMCAS China is more than exhibiting products.
It is an opportunity to exchange scientific knowledge, strengthen international partnerships, and introduce innovative Korean regenerative technologies to physicians and distributors worldwide.
As an official Silver Sponsor, we aim to contribute to the global conversation surrounding skin quality, regenerative medicine, and evidence-based aesthetic practice while building long-term partnerships with professionals who share these values.
Featured Products at IMCAS China 2026
The scientific themes presented at IMCAS China closely reflect the direction of today’s regenerative aesthetic market. As clinical interest continues to shift toward skin quality improvement and biologically driven treatment strategies, BS PHARM KOREA will highlight two flagship regenerative solutions during the congress.
INHILO + – Hybrid Dual HA Skin Booster
Selected to reflect the growing demand for advanced skin quality treatments, INHILO demonstrates BS PHARM KOREA’s approach to Hybrid Dual HA technology.
INHILO+ combines high- and low-molecular-weight cross-linked hyaluronic acid to support hydration, collagen stimulation, and natural-looking skin rejuvenation.
The product reflects the growing clinical interest in long-term skin quality improvement through advanced injectable technologies.
NA:DRN – NAD⁺ & PDRN Regenerative Solution
Designed for regenerative treatment strategies, NA:DRN represents the growing clinical interest in biologically driven skin rejuvenation.
NA:DRN combines NAD⁺ and PDRN to support cellular recovery, tissue regeneration, and healthier skin function.
Its regenerative concept aligns with the increasing demand for evidence-based treatment protocols focused on long-term skin revitalization rather than temporary correction.
Visit BS PHARM KOREA at IMCAS China 2026
📅Date: August 27–29, 2026
🏢Place: W Hotel – The Bund, Shanghai
📍Booth: Level 2, Booth 65
Visitors will have the opportunity to:
- – Explore BS PHARM KOREA’s regenerative aesthetics portfolio
- – Learn the scientific concepts behind INHILO and NA:DRN
- – Discuss international distribution opportunities
- – Meet our global business development team
- – Exchange insights on emerging trends in regenerative aesthetics
Whether you are seeking innovative skin booster technologies or new business partnerships, we look forward to welcoming you in Shanghai.
Looking Ahead
International scientific congresses continue to shape the future of medical aesthetics by connecting clinical research with real-world practice.
At BS PHARM KOREA, participation in IMCAS China reflects our long-term commitment to scientific innovation, professional education, and global collaboration. By engaging with physicians, researchers, and distribution partners from around the world, we aim to contribute to the advancement of regenerative aesthetic medicine while expanding access to innovative Korean solutions.
We look forward to meeting physicians, distributors, and business partners at IMCAS China 2026 as we continue expanding global collaboration in regenerative aesthetics.
Continue Exploring
Explore our Skin Booster Knowledge Series to learn more about formulation technology, treatment objectives, and regenerative aesthetic strategies.
- – Skin Booster Selection Guide | 5 Factors for Aesthetic Clinics
- – Choosing the Right Skin Booster Starts with Formulation
- – Choosing the Right Skin Booster for Different Treatment Objectives
Contact Us – Planning to Visit IMCAS China 2026?
Schedule a meeting with the BS PHARM KOREA team in advance to discuss distribution opportunities, regenerative skin booster solutions, and potential business partnerships.
Frequently Asked Questions
What is IMCAS China 2026?
IMCAS China is one of Asia’s leading scientific congresses dedicated to dermatology, plastic surgery, and medical aesthetics, bringing together physicians, researchers, and industry leaders from around the world.
Why is BS PHARM KOREA participating as a Silver Sponsor?
Our participation reflects our commitment to scientific collaboration, regenerative aesthetic innovation, and long-term global partnerships.
Which products will BS PHARM KOREA present?
We will feature INHILO and NA:DRN, two regenerative solutions developed to support modern skin quality treatments.
Who should visit BS PHARM KOREA Booth ?
Dermatologists, plastic surgeons, aesthetic physicians, distributors, and healthcare professionals interested in Korean regenerative aesthetic solutions are welcome.
Can I schedule a business meeting during IMCAS China 2026?
Yes. Our global business development team welcomes pre-arranged meetings to discuss partnership opportunities and product introductions.
